Australia markets closed

BioSyent Inc. (RX.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
10.37+0.16 (+1.57%)
At close: 03:59PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
7,985
7,865
18,035
20,291
-
Other short-term investments
18,202
20,831
10,176
5,286
-
Total cash
26,187
28,696
28,212
25,578
-
Net receivables
2,798
2,791
2,494
1,599
-
Inventory
5,894
4,535
2,204
2,074
-
Total current assets
35,871
37,143
34,079
29,774
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
3,324
3,264
3,217
3,133
-
Accumulated depreciation
-1,884
-1,591
-1,286
-970.853
-
Net property, plant and equipment
1,440
1,673
1,932
2,162
-
Equity and other investments
2,500
0
-
-
-
Intangible assets
1,153
1,201
874.026
1,008
-
Total non-current assets
5,657
3,342
3,088
3,797
-
Total assets
41,529
40,485
37,167
33,571
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
5,078
5,063
3,563
3,723
-
Taxes payable
111.114
318.005
98.691
250.195
-
Deferred revenues
134.461
164.372
313.632
934.436
-
Other current liabilities
27.285
-
-
78.608
43.861
Total current liabilities
5,534
5,719
4,137
5,139
-
Non-current liabilities
Deferred tax liabilities
197.602
182.382
80.161
79.672
-
Other long-term liabilities
-
1,403
-
-
-
Total non-current liabilities
1,235
1,403
1,475
1,637
-
Total liabilities
6,769
7,123
5,613
6,775
-
Stockholders' equity
Common stock
5,122
5,367
5,797
6,392
-
Retained earnings
27,528
25,910
24,125
19,076
-
Accumulated other comprehensive income
-177.455
-143.144
-185.26
-166.705
-
Total stockholders' equity
34,760
33,363
31,555
26,796
-
Total liabilities and stockholders' equity
41,529
40,485
37,167
33,571
-